共 295 条
[41]
Jarrett RB(2007)Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder Clin Drug Investig 27 481-492
[42]
Keller MB(2007)Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial Curr Med Res Opin 23 245-250
[43]
Kupfer DJ(2007)A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder Curr Med Res Opin 23 1605-1614
[44]
Lavori PW(2003)Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study J Clin Psychopharmacol 23 358-364
[45]
Higgins JJD(2005)Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial J Clin Psychopharmacol 25 471-475
[46]
Barrett J(2006)A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression Am J Geriatr Psychiatry. 14 361-370
[47]
Lu G(2011)Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial Int J Clin Pract 65 323-329
[48]
Ades A(2014)Comparable efficacy and safety of 8 weeks treatment with agomelatine 25–50 mg or fluoxetine 20–40 mg in Asian out-patients with major depressive disorder Asian J Psychiatry. 8 26-32
[49]
White I(1993)A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression J Clin Psychopharmacol 13 18S-22S
[50]
Xie F(2006)A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder Int Clin Psychopharmacol 21 159-169